Loading stock data…
TFC
$50.80+0.85 (+1.70%)
After Hours$50.80+0.00 (+0.00%)· Last close May 6
Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Truist Financial Corporation in the Financial Services sector is trading at $50.84. The stock is currently 10% below its 52-week high of $56.20, remaining 8.7% above its 200-day moving average. Technical signals show neutral RSI of 59 and bearish MACD signal, explaining why TFC maintains its current momentum and trend strength. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 59) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$50.80
Potential Upside
55.4%
Whystock Fair Value$78.96
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus19 analysts
Buy
Mean target$55.63+9.5%
Range$45.00 – $63.00
Fundamentals
Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through two segments, Consumer and Small Business Banking; and Wholesale Banking....
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$63.48B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.61
Beta
Defensive asset. Lower volatility than the S&P 500.
0.87
Div Yield
Strong income play. Yield provides a meaningful total return floor.
408.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.01%
Volume
Today's trading volume
3.82M
Recent News
How The OneWater Marine (ONEW) Investment Story Is Shifting After Analyst Recalibration
OneWater Marine is back in focus after analysts trimmed fair value estimates from $17.00 to $13.50, a reset of about $3.50 that lines up with a series of $2.00 price target cuts across recent reports. Those updates point to a more measured stance, with different firms stressing execution risk and growth potential, while still leaving room for upside in some of their models. As you read on, you will see how these moving targets shape the evolving analyst narrative and what to watch next in the...
Iron Mountain (IRM) Price Target Increased to $140 by Truist
Iron Mountain Inc. (NYSE:IRM) is one of the Best Digital Infrastructure REITs to Buy According to Analysts. On May 1, Truist analyst Tobey Sommer raised the price target on Iron Mountain to $140 from $130 while maintaining a Buy rating on the shares following better-than-expected first-quarter financial results, according to a report by TheFly. In […]
Equinix (EQIX) Raised to $1,215 by Truist Following Q1 Results
Equinix, Inc. (NASDAQ:EQIX) is one of the Best Digital Infrastructure REITs to Buy According to Analysts. On May 1, Truist raised its price target on Equinix to $1,215 from $1,127 and maintained a Buy rating on the shares following the announcement of the company’s first quarter financial results, according to a report by TheFly. Earlier, […]
How The Amneal Pharmaceuticals (AMRX) Story Is Shifting Around The New US$17 Price Target
The fair value estimate for Amneal Pharmaceuticals has been adjusted to US$17.00, closely matching the current US$17.00 analyst price target and slightly below the prior US$17.17 figure. Analysts linking this refined target to the latest Q4 results and FY26 guidance are splitting into more bullish and more cautious camps as they weigh earnings potential against execution risks in GRx and distribution. As you read on, you will see how this evolving narrative might shape the way you track...
How The Cimpress (CMPR) Narrative Is Shifting With New Price Targets And Buyback Plans
Cimpress is back in focus after the latest analyst work lifted its fair value price target from US$97.50 to US$102.50, a modest reset that matters if you are tracking valuation updates closely. Bulls see the new target as better aligned with recent Street research, while bears question how much conviction to place on the underlying assumptions that support it. Read on to see what is driving the shift in views and how you can keep up with the evolving Cimpress story. Stay updated as the Fair...